The present invention relates to peptides and use of said peptides in methods of inhibiting fusion between the virion envelope of Flaviviruses and membranes of the target cell, the process that delivers the viral genome into the cell cytoplasm. The invention provides also for pharmaceutical compositions comprising said peptides or peptide derivatives. The invention also relates to antibodies specific for said peptides.